These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25141276)

  • 21. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
    Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
    J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies.
    Terajima M; Cruz J; Co MD; Lee JH; Kaur K; Wrammert J; Wilson PC; Ennis FA
    J Virol; 2011 Dec; 85(24):13463-7. PubMed ID: 21994454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children.
    Ng S; Fang VJ; Ip DK; Chan KH; Leung GM; Peiris JS; Cowling BJ
    J Infect Dis; 2013 Oct; 208(8):1320-4. PubMed ID: 23908481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
    Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
    Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemagglutination Inhibition Antibody Response Following Influenza A(H1N1)pdm09 Virus Natural Infection: A Cross-Sectional Study from Thirthahalli, Karnataka, India.
    Alladi CSH; Jagadesh A; Prabhu SG; Arunkumar G
    Viral Immunol; 2019 Jun; 32(5):230-233. PubMed ID: 31070522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel correlates of protection against pandemic H1N1 influenza A virus infection.
    Ng S; Nachbagauer R; Balmaseda A; Stadlbauer D; Ojeda S; Patel M; Rajabhathor A; Lopez R; Guglia AF; Sanchez N; Amanat F; Gresh L; Kuan G; Krammer F; Gordon A
    Nat Med; 2019 Jun; 25(6):962-967. PubMed ID: 31160818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections.
    Karunarathna HMTK; Perera RAPM; Fang VJ; Yen HL; Cowling BJ; Peiris M
    Emerg Microbes Infect; 2019; 8(1):404-412. PubMed ID: 30898033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus.
    Srivastava V; Yang Z; Hung IF; Xu J; Zheng B; Zhang MY
    J Virol; 2013 May; 87(10):5831-40. PubMed ID: 23487456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Wells J; Arden N; Niño D; Belmont JW
    J Infect Dis; 2013 Mar; 207(6):974-81. PubMed ID: 23307936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity-mediating antibodies in HIV-infected Indian individuals.
    Nehul S; Kulkarni A; Pawar S; Godbole S; Ghate M; Thakar M
    Infect Dis (Lond); 2018 Jan; 50(1):35-43. PubMed ID: 28776433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between antibody titers and protection against influenza virus infection within households.
    Tsang TK; Cauchemez S; Perera RA; Freeman G; Fang VJ; Ip DK; Leung GM; Malik Peiris JS; Cowling BJ
    J Infect Dis; 2014 Sep; 210(5):684-92. PubMed ID: 24676208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
    Hoschler K; Maharjan S; Whitaker H; Southern J; Okai B; Baldevarona J; Turner PJ; Andrews NJ; Miller E; Zambon M
    Vaccine; 2020 Mar; 38(12):2660-2670. PubMed ID: 32070679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
    Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
    Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
    de Vries RD; Nieuwkoop NJ; Pronk M; de Bruin E; Leroux-Roels G; Huijskens EGW; van Binnendijk RS; Krammer F; Koopmans MPG; Rimmelzwaan GF
    Vaccine; 2017 Jan; 35(2):238-247. PubMed ID: 27914742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of Serological Responses in Critically Ill Patients Hospitalized With 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009-2011.
    Rolfes MA; Gross FL; Flannery B; Meyers AFA; Luo M; Bastien N; Fowler RA; Katz JM; Levine MZ; Kumar A; Uyeki TM;
    J Infect Dis; 2018 Mar; 217(7):1078-1088. PubMed ID: 29342251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children.
    Verschoor CP; Singh P; Russell ML; Bowdish DM; Brewer A; Cyr L; Ward BJ; Loeb M
    PLoS One; 2015; 10(6):e0131531. PubMed ID: 26107625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection.
    Walters KA; Zhu R; Welge M; Scherler K; Park JK; Rahil Z; Wang H; Auvil L; Bushell C; Lee MY; Baxter D; Bristol T; Rosas LA; Cervantes-Medina A; Czajkowski L; Han A; Memoli MJ; Taubenberger JK; Kash JC
    mBio; 2019 May; 10(3):. PubMed ID: 31088926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.